-
Most Popular
Earnings Reports
AURA Stock Earnings: Aura Biosciences Beats EPS for Q2 2024
AURA stock results show that Aura Biosciences beat analyst estimates for earnings per share the second quarter of 2024.
XTNT Stock Earnings: Xtant Medical Hldgs Misses EPS, Beats Revenue for Q2 2024
XTNT stock results show that Xtant Medical Hldgs missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
RXRX Stock Earnings: Recursion Pharmaceuticals Meets EPS, Beats Revenue for Q2 2024
RXRX stock results show that Recursion Pharmaceuticals met analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
EWTX Stock Earnings: Edgewise Therapeutics Beats EPS for Q2 2024
EWTX stock results show that Edgewise Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
PBSFY Stock Earnings: ProSiebenSat 1 Media Reported Results for Q2 2024
ProSiebenSat 1 Media just reported results for the second quarter of 2024.
KBCSY Stock Earnings: KBC Group Reported Results for Q2 2024
KBC Group just reported results for the second quarter of 2024.
MITEY Stock Earnings: Mitsubishi Estate Co Reported Results for Q1 2025
Mitsubishi Estate Co just reported results for the first quarter of 2025.
LPCN Stock Earnings: Lipocine Beats EPS, Misses Revenue for Q2 2024
LPCN stock results show that Lipocine beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
NATH Stock Earnings: Nathan’s Famous Reported Results for Q1 2025
Nathan's Famous just reported results for the first quarter of 2025.
NUVL Stock Earnings: Nuvalent Misses EPS for Q2 2024
NUVL stock results show that Nuvalent missed analyst estimates for earnings per share the second quarter of 2024.
BNRE Stock Earnings: Brookfield Reinsurance Reported Results for Q2 2024
Brookfield Reinsurance just reported results for the second quarter of 2024.
QTTB Stock Earnings: Q32 Bio Misses EPS for Q2 2024
QTTB stock results show that Q32 Bio missed analyst estimates for earnings per share the second quarter of 2024.
RNAC Stock Earnings: Cartesian Therapeutics Beats EPS, Beats Revenue for Q2 2024
RNAC stock results show that Cartesian Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
TRVN Stock Earnings: Trevena Beats EPS for Q2 2024
TRVN stock results show that Trevena beat analyst estimates for earnings per share the second quarter of 2024.
VERV Stock Earnings: Verve Therapeutics Beats EPS, Beats Revenue for Q2 2024
VERV stock results show that Verve Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
STER Stock Earnings: Sterling Check Misses EPS, Beats Revenue for Q2 2024
STER stock results show that Sterling Check missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
ITOS Stock Earnings: ITeos Therapeutics Beats EPS for Q2 2024
ITOS stock results show that ITeos Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
PASG Stock Earnings: Passage Bio Beats EPS for Q2 2024
PASG stock results show that Passage Bio beat analyst estimates for earnings per share the second quarter of 2024.
FHTX Stock Earnings: Foghorn Therapeutics Beats EPS, Beats Revenue for Q2 2024
FHTX stock results show that Foghorn Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
